Novick Biosciences

Discovery Chemistry

Novick Bio is accelerating in assisting within Integrated services for numerous therapeutic areas – Oncology, CNS, Diabetic, Inflammatory etc., in propelling the Drug Discovery objectives of Global Pharmaceutical Organizations and Academics. Novick Bio accommodates strong team of Scientists/Associates who have well versed with the total Drug Discovery cycle, includes, Identification of HIT, HIT to LEAD and Lead Optimization. Ensures shorter turnaround times for the design, synthesis and characterization of large libraries followed by SAR studies with bioisosteric modifications. Novick Bio has well equipped in house analytical services department to evaluate the physicochemical properties for synthesized candidates.

Medicinal Chemistry

  • Hit identification, Hit to Lead Development
  • Lead Optimization with a focus on improving potency and efficacy
  • Lead compound scale-up for advanced studies
  • Synthesis of new scaffolds of any structural complexity
  • Problem solving – synthetic discovery, SAR analysis, ADMET related issues
  • Multiple therapeutic area expertise

Parallel Chemistry

  • Diversity based library synthesis for corporate compound collections
  • Focused & fragment based library for target based synthesis
  • Secured data collection and data management of synthesized libraries

Custom Synthesis

  • Design & Synthesis of Building Blocks/Scaffolds
  • Focused library synthesis
  • Multi-step complex chemistry for
  • Chiral Synthesis
  • Reference Standards
  • Nucleotides & Peptides

Chemistry Capabilities:

  • Heterocyclic Chemistry
  • Chiral Chemistry
  • Peptide Chemistry


  • Carbohydrate Chemistry
  • Nucleoside & Nucleotide Chemistry
  • Natural Product Chemistry